Biostatistics, Epidemiology & Research Design (BERD)

Building Strong Research

The BERD Core provides support in the areas of biostatistics, epidemiology, and research design. Services include consultations on study design for clinical trials, community-based participatory research, and population-based studies; quantitative data analysis; and protocol review. 


Biostatistics Stock Image

BERD Services:

Study Design

Study design consultations occur at the initial stage of study planning, preferably before IRB submission. Design issues vary by study type (clinical trial, community-based participatory research, healthcare big data or population-based study). Potential topics for consultation include:

  • statistical analysis plan
  • endpoint determination
  • randomization schedules and implementation
  • identification of population risk sets and exposures
  • protocol review
  • sample size considerations and calculations
  • eligibility criteria for prospective studies and healthcare big data
  • conversion of research data management to analysis datasets
  • pilot study planning and letter of intent (LOI) development
  • development of extramural grant application

Request This Service »  

Data Analysis

Data analysis consultations occur throughout the project from initial planning to dissemination. Support is available for most quantitative data analysis methods. In addition, the BERD is available to support dissemination of findings by creating effective graphical summaries of project data. To support data management and stakeholder communication, summary reports and executive summaries can be produced at regular, predetermined intervals. Final materials (e.g. analysis plans, tables and figures, analytical write-ups) will be provided based on timelines and goals established at initial consultations. Research within team science is an iterative and ongoing process, so materials will be stored and maintained through project completion. Support for secondary data analysis is available within the areas of clinical interest for each BERD member. 

Request This Service »  



  • Opinion: Herd immunity is almost here. But what does that mean?
    • Oct 8 2021

    Opinion by John M. Barry 10/7/2021 at 4:59 p.m. EDT John M. Barry is the author of “The Great Influenza: The Story of the Deadliest Pandemic in History” and distinguished scholar at Tulane University’s School of Public Health and Tropical Medicine.

  • UK Receives $23.5 Million Clinical and Translational Science Award from the NIH
    • Sep 14 2021

    The University of Kentucky Center for Clinical and Translational Science (CCTS) has received a $23.5 million, four-year award from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health. This is the third time the CCTS has successfully competed for the prestigious Clinical and Translational Award (CTSA), with continuous funding since 2011 totaling $65.4 million in research dollars.

  • 'UK at the Half': UK CCTS Accelerating Discoveries to Improve Health
    • Sep 14 2021

    During "UK at the Half" UK football game on Saturday, CCTS was recognized for their clinical research — which helps to improve health, with an emphasis on the Central Appalachian region.